The future of damage assessment in vasculitis.

The future of damage assessment in vasculitis.

Item
http://www.wikidata.org/entity/Q36841761
Development of an IgG4-RD Responder Index.Patient-reported outcome assessment in vasculitis may provide important data and a unique perspectiveVasculitis: lessons learned.Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.Current status of outcome measure development in vasculitis.The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment IndexAssessment of damage in vasculitis: expert ratings of damage.An approach to the diagnosis and management of systemic vasculitis.Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a randomized controlled trial.Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis.
P2860

The future of damage assessment in vasculitis.

Item
http://www.wikidata.org/entity/Q36841761
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The future of damage assessment in vasculitis.
@en
type
label
The future of damage assessment in vasculitis.
@en
prefLabel
The future of damage assessment in vasculitis.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P1433
P1476
The future of damage assessment in vasculitis
@en
P2093
P304
P31
P407
P433
P478
P50
P577
P698